Please Enter a Search Term

Dr. Debbie Kelly

Dr. Debbie Kelly

Associate Professor, Cross Appointment to the Faculty of Medicine
dvkelly@mun.ca
Phone: 709 777 7903
TC129

Currently, Dr. Kelly is not accepting any graduate students.

Education

  • May 1999 - Doctor of Pharmacy, University of Toronto, Toronto, ON
  • June 1997 - CSHP Accredited Hospital Pharmacy Residency, Queen Elizabeth II Health Science Centre, Halifax, NS / Dalhousie University, Halifax, NS
  • April 1996 - Bachelor of Science, Pharmacy, Memorial University of Newfoundland, St. John’s, NL


Publications/Posters

  • Rosen C, Kelly D, Hoo A, Francois. Ask the Experts: The Skinny on Skin. Interview by Jennifer McPhee. The Positive Side, Winter 2010. Vol.11;No.2:26-7.
  • Kelly D., Young S., Bishop L., Colbourne S., Hawboldt J., Keough M., O'Shea P., Phillips L., West R., Young J. "Community Pharmaceutical Care Program: A study of collaborative practice for diabetes management in Newfoundland and Labrador." 2009
  • Bader MS, Kelly DV. Diagnosis and management of common chronic metabolic complications in HIV-infected patients. Postgrad Med 2008;120(4):17-27.
  • Kelly DV, Young S, Bishop L, Phillips L, Hawboldt J, Keough TM, O’Shea P, Young J, Colbourne SA, West R. Family physician and community pharmacists views on collaborative practice in Newfoundland and Labrador. Poster Presentation, Family Practice Forum, November 2008.
  • Hughes CA, Foisy MM, Dewhurst N, Higgins N, Robinson L, Kelly DV, Lechelt KE. Comment: Abacavir hypersensitivity reaction: an update. Ann Pharmacother 2008;42(10):1519-20; author reply 1520-21. Epub 2008 Sep 9.
  • Hughes CA, Foisy M, Higgins N, Robinson L, Kelly DV, Lechelt KE. Abacavir Hypersensitivity Reaction: an Update. Ann Pharmacother 2008;42(3):387-96. Epub 2008 Feb 26.
  • Hawboldt J, Young S, Bishop L, Colbourne A, Kelly D, Phillips L, West R, Young J. Expanding the Practical Diabetes Management Program for an Innovative Training Workshop. Poster Presentation, Canadian Diabetes Association Professional Conference, October 2007.
  • Bishop L, Phillips L, Kelly D, Young S, Colbourne A, Hawboldt J, West R, Young J. The Community Pharmaceutical Care Program. Bridging the Gap for Diabetes Care in Newfoundland Labrador: An Innovative Training Workshop. Poster Presentation, Canadian Association of Continuing Health Education conference, October 2007.
  • Kelly DV, MacDonald D, Priddle M, Healey M. Profiling Prescription Medication Utilization in Newfoundland and Labrador: Optimizing the Quality of Drug Therapy. December 17, 2003, Final Report, available at: http://www.nlchi.nf.ca/pdf/drug_utilization.pdf
  • Sheehan NL, Kelly DV, Tseng AL, van Heeswijk RPG, Beique LC, Hughes CA. Evaluation of HIV drug interaction websites. Ann Pharmacother 2003; 37: 1577 – 1586.
  • Kelly DV. Quick update: Post-exposure prophylaxis. Canadian Journal of CME, November 2002.
  • Rahman P, Stone C, Kelly D, Lilly R, Scaplen R. Grands Rounds: Perspective on osteoarthritis. Patient Care Canada, September 2002. Vol.13;No.9:S1-S8.
  • Kelly DV, Beique LC, Bowmer MI. Extrapyramidal symptoms with ritonavir/indinavir plus risperidone. Ann Pharmacother 2002; 36: 827-30.
  • Walmsley SL, Kelly DV, Tseng AL, Humar A, Harrigan PR. Non-nucleoside reverse transcriptase inhibitor failure impairs HIV-RNA responses to efavirenz-containing salvage antiretroviral therapy. AIDS 2001;15:1581-1584
  • Walmsley S, Harris DV*, Chantler P, Samuel J, Tseng A. “Predictors of Antiretroviral Efficacy and Tolerability of Efavirenz in a Clinic Population”. Seventh European Conference on Clinical Aspects and Treatment of HIV-Infection, October 1999.
  • Harris DV*, Tseng A, Waring V, Chantler P, Walmsley S. “Efficacy and Tolerability of Efavirenz Among HIV Clinic Patients”. Oral poster presentation, Eighth Annual Canadian Conference on HIV/AIDS Research, May 1999.
  • Harris DV*, Kelly KG. Pump it up! A critical look at the use of nutritional supplements to boost athletic performance. Pharmacy Practice Feb 1999; 15(2): 54-6, 58-60, 62,64.
  • Wyllie ARJ, Elms LL, Harris DV*, Butler K, Einerson T. “Lithium Augmentation in Treatment-Resistant Depression: A Meta-analysis” Canadian Society of Hospital Pharmacists Professional Practice Conference, Toronto, ON, February 1998.
  • Harris DV*. “Provision of Seamless Pharmaceutical Care to Patients between a Tertiary Care Teaching Hospital and a Nursing Home”. Residency Project, June 1997.
  • Harris, DV*. Nutritional supplementation in bodybuilders: Role of the pharmacist. The Pharmacist Feb/Mar 1997; 13(4): 10-1.
  • Harris DV*. Benzodiazepines: Abused or maligned? The Distillate Nov/Dec 1996; 22(4): 15-7.


* Published under maiden name

Invited Presentations

  • “Post-Exposure Prophylaxis” Department of Medicine, Memorial University, Academic Half Day for Internal Medicine Residents, June 2010.
  • “Medication Use in Pregnancy” Department of Medicine, Memorial University, Academic Half Day for Internal Medicine Residents, March 2009.
  • “Drug Use in Breastfeeding” Department of Medicine, Memorial University, Academic Half Day for Internal Medicine Residents, March 2009.
  • “HIV Management is a Team Effort” Moderator: Panel discussion, Professional Development Week, St. John’s, January 2009.
  • “The Pharmacist as a Partner in HIV Care” Professional Development Week, St. John’s, January 2009.
  • “Community Pharmaceutical Care Project Study Results” PANL Annual General Meeting and Conference, St. John’s, October 2008.
  • “HAART of the Matter: A case-based program on HIV management” HIV Team Rounds presentation, St. John’s, May 2006.
  • “AACT in Hypertension: The Pharmacist’s Intervention” CSHP-NL/PANL Continuing Education Program, Conception Bay North, May 2006.
  • “Understanding and Managing Cardiovascular Risk Factors: A primer for community pharmacists, part II” CSHP-NL/PANL Continuing Education Program, St. John’s, March 2006.
  • “A Practical Approach to Managing HIV Drug Interactions” CSHP Professional Practice Conference, Toronto, January 2006.
  • “Understanding and Managing Cardiovascular Risk Factors: A primer for community pharmacists, part I” CSHP-NL/PANL Continuing Education Program, St. John’s, November 2005.
  • “Pharmacists in Ambulatory Care: A model in HIV Care” Atlantic Pharmacy Advancement Conference, St. John’s, St. John’s, November 2005.
  • “The Pharmacist, Your Partner in Healthy Living” 15th Annual General Meeting and Conference, NL Public Sector Pensioners’ Association, St. John’s, October 2005.
  • “The Community Pharmaceutical Care Program” PANL Annual General Meeting and Conference, Gander, September 2005.
  • “Antiretrovirals and Liver Dysfunction” Atlantic Collaboration on HIV Education conference, St. John’s, September 2005.
  • “Medication Use Among Seniors in NL: Benchmarks and Opportunities for Improvement” Presentation to Provincial Seniors Policy and Programs Committee, March 2005.
  • “Osteoporosis” Wal-Mart Pharmacy Seniors Health Fair, July 2004.
  • “Inappropriate Medication Use in the Elderly” Twillingate Primary Care Team Videoconference, November 2003.
  • “The ‘Heart Ache’ of Coxibs: Do they increase the risk of MI?” Canadian Society of Hospital Pharmacists, Annual General Meeting, August 2003.
  • “HIV Round Table Discussion” Stephenville, Continuing Education Program, August 2003.
  • “Managing Lipid Abnormalities in HIV-Infected Patients. A Case-Based Workshop” HIV Clinic Group Evening Continuing Education Program, May 2003.
  • “Long Acting Beta-Agonists: Is there a Difference?" Canadian Society of Hospital Pharmacists, Continuing Education Program, May 2003.
  • “Research Made Easy: An Interactive Workshop” Canadian Society of Hospital Pharmacists, Continuing Education Program, January 2003.
  • “Understanding Cytochrome P450 Drug Interactions” Department of Medicine, Memorial University, Academic Half Day for Internal Medicine Residents, November 2002.
  • “HIV Post-Exposure Prophylaxis” Infection Control Education Day, Health Care Corporation of St. John’s, November 2002.
  • “HIV Post-Exposure Prophylaxis: A Primer for Pharmacists” Newfoundland Pharmaceutical Association Annual Conference, September 2002.
  • “HIV Post-Exposure Prophylaxis” Community and Hospital Infection Control Association(Canada) Conference, June 2002.
  • “HIV Therapeutics Update: Review of Current Treatment Guidelines & Overview of Antiretroviral Agents” Department of Medicine, Memorial University, Academic Half Day for Internal Medicine Residents, April 2002.
  • “Pharmacists Caring for the Elderly: Challenges and Opportunities” Canadian Association for Pharmacy Students and Interns Professional Development Week Conference, January 2002.
  • “HIV Round Table Discussion” Corner Brook, Continuing Education Program, September 2001.
  • “Interdisciplinary Treatment for Patients with HIV: a case discussion” Corner Brook, Continuing Education Program, May 2001.
  • “New Treatment Options for Osteoarthritis” Prince Edward Island Pharmacy Board, Continuing Education Program, May 2001.
  • “Health Technology Assessment in Daily Practice” CCOHTA Health Technology Assessment Workshop, Panel Presentation and Discussion, May 2001.
  • “HIV: Is the Treatment Worse than the Disease?” Health Care Corporation of St. John’s, Medical Grand Rounds, December 2000.
  • “HIV: Is the Treatment Worse than the Disease?” Corner Brook, Continuing Education Program, December 2000.
  • “Assessing the Pharmacologic Management of Behavioural Problems Associated with Dementia at the Veteran’s Pavilion: A Retrospective Study” Health Care Corporation of St. John’s, Research Project Presentation, November 2000.
  • “Symptom Management of Osteoarthritis: The Role of the Pharmacist” New Brunswick Pharmacists’ Association, Continuing Education Program, October 2000. Updated and repeated for the Newfoundland Pharmaceutical Association in May 2001 at St. John’s and Gander, and in June 2001 in Corner Brook.
  • “Synercid: A Magic Bullet for Multi-Drug Resistant Infections?” Health Care Corporation of St. John’s, Continuing Education Program, June 2000.
  • “Current Concepts in the Management of Osteoporosis” Canadian Society of Hospital Pharmacists, Continuing Education Program, March 2000.
  • “Antibiotics: Use and Misuse” Community and Health Infection Control Association of Newfoundland and Labrador, Annual Meeting, September 1999.
  • “Management of Protease inhibitor-Induced Hyperlipidemia: To Treat or Not to Treat?” School of Pharmacy, Memorial University of Newfoundland, April 1999.
  • “Understanding Cytochrome P450 Drug Interactions” Division of Family Practice,St. Michael’s Hospital, Health Centre at 410,February 1999.
  • “Cyclosporine, Tacrolimus and Neurotoxicity: Mitigating Factors and Management” Division of Critical Care, Hospital for Sick Children, December 1998.
  • “Does Nefazodone Cause Less Sexual Dysfunction than TCAs or SSRIs?” Pharm. D Seminar, University of Toronto, April 1998.
  • “Is Renal Dysfunction a Contraindication to the Use of ACE Inhibitors in CHF?” Pharm. D Seminar, University of Toronto, February 1998.
  • “Use of Inhaled Antibiotics in Cystic Fibrosis Patients” Department of Pharmacy, Queen Elizabeth II Health Science Centre, October 1996.
  • “Thalidomide to Treat Aphthous Ulcers” Division of Infectious Diseases, Queen Elizabeth II Health Science Centre, October 1996; repeated for HIV Clinic Rounds, December 1996.



Awards and Scholarships

  • Bristol-Myers Squibb Award for Excellence in Pharmaceutical Teaching, 2010
  • J. Frank Janes Meritorious Service Award (PANL), 2009
  • Scholar to the Centre for Collaborative Health Professional Education, 2002-05
  • Health Care Corporation of St. John’s Purple Award, 2005
  • Bristol-Myers Squibb Award for Excellence in Pharmaceutical Teaching, 2002
  • Health Care Corporation of St. John’s Purple Award, 2000.
  • Bristol-Myers Squibb Award for Excellence in Pharmaceutical Teaching, 2000
  • Canadian Association for HIV Research New Investigator Award, 1999
  • Apotex / PACE Seminar Award, 1999
  • Canadian Foundation for Pharmacy Support Grant for Advanced Training in Clinical Practice, 1997-98
  • Memorial University School of Pharmacy Award in Clinical Pharmacy, 1996
  • Dr. L.R. Hensman Award in Patient Counselling, 1996
  • 1st Place, Regional CAPSI-Sponsored Compounding Competition, 1995-96
  • 1st Place, Regional CAPSI-Sponsored Patient Counselling Competition, 1995-96
  • 4th Place – National CAPSI-Sponsored Patient Counselling Competition, 1995-96
  • 2nd Place – Regional CAPSI-Sponsored Patient Counselling Competition, 1994-95
  • Foundation for Education Award, 1990
  • MO Morgan Entrance Scholarship, 1990
Share